Provided by Tiger Trade Technology Pte. Ltd.

PolyPid Ltd.

5.14
+0.07001.38%
Post-market: 5.14-0.00010.00%19:42 EDT
Volume:56.03K
Turnover:283.46K
Market Cap:104.40M
PE:-3.48
High:5.15
Open:5.08
Low:5.00
Close:5.07
52wk High:5.73
52wk Low:3.06
Shares:20.31M
Float Shares:12.16M
Volume Ratio:0.50
T/O Rate:0.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4762
EPS(LYR):-2.0900
ROE:-243.59%
ROA:-74.63%
PB:19.38
PE(LYR):-2.46

Loading ...

Analysts Are Bullish on These Healthcare Stocks: PolyPid (PYPD), Equillium (EQ)

TIPRANKS
·
Aug 14

PolyPid Earnings Call: Priority Review, Big Azurity Deal

TIPRANKS
·
Aug 13

PolyPid Posts Wider H1 2026 Loss as Assets and Equity Decline

TIPRANKS
·
Aug 13

Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD)

TIPRANKS
·
Aug 13

PolyPid Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

PolyPid Q2 FY26 Net Loss Narrows 22% to $7.8 Million

Reuters
·
Aug 12

PolyPid Q2 EPS $(0.35) Beats $(0.38) Estimate

Benzinga Earnings
·
Aug 12

Press Release: PolyPid Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 12

PolyPid Ltd Expected to Post a Loss of 38 Cents a Share - Earnings Preview

Reuters
·
Aug 10

PolyPid to Report Q2 2026 Results, Host Conference Call

Reuters
·
Jul 30

PolyPid to Report Second Quarter 2026 Financial Results and Operational Highlights on August 12, 2026

GlobeNewswire
·
Jul 30

PolyPid NDA acceptance ‘meets or exceeds’ expectations, says Roth Capital

TIPRANKS
·
Jul 29

PolyPid Wins FDA Priority Review for D-PLEX100 NDA, Accelerating Path to Market

TIPRANKS
·
Jul 29

PolyPid Says FDA Accepts D-plex100 NDA, Grants Priority Review

Reuters
·
Jul 29

PolyPid - FDA Sets Pdufa Target Action Date of November 28, 2026 for D-Plex100

THOMSON REUTERS
·
Jul 29

PolyPid - FDA Acceptance Triggers $15 Mln Milestone Payment, Completing $30 Mln in Payments

THOMSON REUTERS
·
Jul 29

PolyPid Announces FDA Acceptance of Nda with Priority Review for D-Plex₁₀₀

THOMSON REUTERS
·
Jul 29

PolyPid price target lowered to $12 from $13 at Craig-Hallum

TIPRANKS
·
Jul 22

Roth says Azurity deal validates D-PLEX100, sees limited near-term revenue

TIPRANKS
·
Jul 22

Polypid Price Target Maintained with a $13.00/share by HC Wainwright & Co.

Dow Jones
·
Jul 22